Skip to content

Clinical trials

Phase 1 Immunoglobulin Light-chain Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Phase 1 Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20041
20071
20083
20091
20111
20131
20141
20171
20181
20201
20213
20222
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated7
Active, not recruiting2
Recruiting2
Unknown status2
Enrolling by invitation1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Northwestern University3
University of Tennessee3
Attralus, Inc.2
Alexion Pharmaceuticals, Inc.1
Alliance for Clinical Trials in Oncology1
Barbara Ann Karmanos Cancer Institute1
California Cancer Consortium1
Eastern Cooperative Oncology Group1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis36
Multiple Myeloma18
Burkitt Lymphoma16
Leukemia, Lymphocytic, Chronic, B-Cell16
Lymphoma, Follicular16
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Large-Cell, Immunoblastic16
Lymphoma, Mantle-Cell16
Lymphoma, Non-Hodgkin16
Neoplasms, Plasma Cell16

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.